1.
Albertsson-Lindblad A, Palsdottir T, Smedby KE, Weibull CE, Glimelius I, Jerkeman M. Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017. Haematologica; https://doi.org/10.3324/haematol.2021.279037 [Early view].